| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ... Nature medicine 20 (5), 548-554, 2014 | 2207 | 2014 |
| Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ... Nature biotechnology 34 (5), 547-555, 2016 | 1050 | 2016 |
| Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry J Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ... Annals of Oncology 30 (8), 1321-1328, 2019 | 1007 | 2019 |
| Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial E Felip, N Altorki, C Zhou, T Csőszi, I Vynnychenko, O Goloborodko, ... The Lancet 398 (10308), 1344-1357, 2021 | 869 | 2021 |
| Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer LV Sequist, JC Soria, JW Goldman, HA Wakelee, SM Gadgeel, A Varga, ... New England Journal of Medicine 372 (18), 1700-1709, 2015 | 817 | 2015 |
| Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ... Cancer discovery 7 (12), 1394-1403, 2017 | 782 | 2017 |
| American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non … VL Keedy, S Temin, MR Somerfield, MB Beasley, DH Johnson, ... Journal of clinical oncology 29 (15), 2121-2127, 2011 | 771 | 2011 |
| Lung cancer incidence in never-smokers HA Wakelee, ET Chang, SL Gomez, THM Keegan, D Feskanich, ... Journal of clinical oncology: official journal of the American Society of …, 2007 | 736 | 2007 |
| COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study MC Garassino, JG Whisenant, LC Huang, A Trama, V Torri, F Agustoni, ... The Lancet Oncology 21 (7), 914-922, 2020 | 646 | 2020 |
| Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ... Nature communications 7 (1), 1-15, 2016 | 612 | 2016 |
| Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018 | 600 | 2018 |
| Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor Z Piotrowska, MJ Niederst, CA Karlovich, HA Wakelee, JW Neal, ... Cancer discovery 5 (7), 713-722, 2015 | 501 | 2015 |
| Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 451 | 2020 |
| First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers BI Sikic, N Lakhani, A Patnaik, SA Shah, SR Chandana, D Rasco, ... Journal of Clinical Oncology 37 (12), 946, 2019 | 429 | 2019 |
| Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial RT Chlebowski, AG Schwartz, H Wakelee, GL Anderson, ML Stefanick, ... The Lancet 374 (9697), 1243-1251, 2009 | 373 | 2009 |
| Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with … L Crino, MJ Ahn, F De Marinis, HJM Groen, H Wakelee, T Hida, T Mok, ... Journal of Clinical Oncology 34 (24), 2866-2873, 2016 | 371 | 2016 |
| Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone, D Owen, R Camidge, ... Journal of Clinical Oncology 35 (13), 1403, 2017 | 345 | 2017 |
| Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ... Journal of Thoracic Oncology 16 (10), 1647-1662, 2021 | 340 | 2021 |
| EGFR-mutant adenocarcinomas that transform to small-cell lung cancer and other neuroendocrine carcinomas: clinical outcomes N Marcoux, SN Gettinger, G O’Kane, KC Arbour, JW Neal, H Husain, ... Journal of Clinical Oncology 37 (4), 278, 2019 | 336 | 2019 |
| Scientific advances in lung cancer 2015 AS Tsao, GV Scagliotti, PA Bunn Jr, DP Carbone, GW Warren, C Bai, ... Journal of Thoracic Oncology 11 (5), 613-638, 2016 | 334 | 2016 |
